Copyright © 2010 Kazumasa Hiroishi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. Q.-L. Choo, G. Kuo, A. J. Weiner, L. R. Overby, D. W. Bradley, and M. Houghton, “Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome,” Science, vol. 244, no. 4902, pp. 359–362, 1989.
2. K. L. Yap, G. L. Ada, and I. F. C. McKenzie, “Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus,” Nature, vol. 273, no. 5659, pp. 238–239, 1978.
3. R. M. Zinkernagel, E. Haenseler, T. Leist, A. Cerny, H. Hengartner, and A. Althage, “T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus. Liver cell destruction by H-2 class I-restricted virus-specific cytotoxic T cells as a physiological correlate of the 51Cr-release assay?” Journal of Experimental Medicine, vol. 164, no. 4, pp. 1075–1092, 1986.
4. C. E. Samuel, “Antiviral actions of interferons,” Clinical Microbiology Reviews, vol. 14, no. 4, pp. 778–809, 2001. View at Publisher · View at Google Scholar · View at PubMed
5. Y.-J. Liu, H. Kanzler, V. Soumelis, and M. Gilliet, “Dendritic cell lineage, plasticity and cross-regulation,” Nature Immunology, vol. 2, no. 7, pp. 585–589, 2001. View at Publisher · View at Google Scholar · View at PubMed
6. H. Watarai, E. Sekine, S. Inoue, R. Nakagawa, T. Kaisho, and M. Taniguchi, “PDC-TREM, a plasmacytoid dendritic cell-specific receptor, is responsible for augmented production of type I interferon,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 8, pp. 2993–2998, 2008. View at Publisher · View at Google Scholar · View at PubMed
7. A. Ahmad and F. Alvarez, “Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis,” Journal of Leukocyte Biology, vol. 76, no. 4, pp. 743–759, 2004. View at Publisher · View at Google Scholar · View at PubMed
8. J. Banchereau and R. M. Steinman, “Dendritic cells and the control of immunity,” Nature, vol. 392, no. 6673, pp. 245–252, 1998. View at Publisher · View at Google Scholar · View at PubMed
9. D. Kägi, F. Vignaux, B. Ledermann, et al., “Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity,” Science, vol. 265, no. 5171, pp. 528–530, 1994.
10. H. Kojima, N. Shinohara, S. Hanaoka, et al., “Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes,” Immunity, vol. 1, no. 5, pp. 357–364, 1994.
11. K. Ando, K. Hiroishi, T. Kaneko, et al., “Perforin, Fas/Fas ligand, and TNF-$\alpha$ pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL,” Journal of Immunology, vol. 158, no. 11, pp. 5283–5291, 1997.
12. K. Ando, T. Moriyama, L. G. Guidotti, et al., “Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis,” Journal of Experimental Medicine, vol. 178, no. 5, pp. 1541–1554, 1993. View at Publisher · View at Google Scholar
13. H. Doi, K. Hiroishi, T. Shimazaki, et al., “Magnitude of $\text{CD}{8}^{+}$ T-cell responses against hepatitis C virus and severity of hepatitis do not necessarily determine outcomes in acute hepatitis C virus infection,” Hepatology Research, vol. 39, no. 3, pp. 256–265, 2009. View at Publisher · View at Google Scholar · View at PubMed
14. G. M. Lauer, E. Barnes, M. Lucas, et al., “High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection,” Gastroenterology, vol. 127, no. 3, pp. 924–936, 2004. View at Publisher · View at Google Scholar
15. D. Yerly, D. Heckerman, T. M. Allen, et al., “Increased cytotoxic T-lymphocyte epitope variant cross-recognition and functional avidity are associated with hepatitis C virus clearance,” Journal of Virology, vol. 82, no. 6, pp. 3147–3153, 2008. View at Publisher · View at Google Scholar · View at PubMed
16. K. Hiroishi, H. Kita, M. Kojima, et al., “Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection,” Hepatology, vol. 25, no. 3, pp. 705–712, 1997. View at Publisher · View at Google Scholar · View at PubMed
17. S. Zeuzem, “Hepatitis C virus: kinetics and quasispecies evolution during anti-viral therapy,” Forum, vol. 10, no. 1, pp. 32–42, 2000.
18. S. Guglietta, A. R. Garbuglia, L. Salichos, et al., “Impact of viral selected mutations on T cell mediated immunity in chronically evolving and self limiting acute HCV infection,” Virology, vol. 386, no. 2, pp. 398–406, 2009. View at Publisher · View at Google Scholar · View at PubMed
19. A. L. Hughes, M. A. K. Hughes, and R. Friedman, “Variable intensity of purifying selection on cytotoxic T-lymphocyte epitopes in hepatitis C virus,” Virus Research, vol. 123, no. 2, pp. 147–153, 2007. View at Publisher · View at Google Scholar · View at PubMed
20. A. Maki, M. Matsuda, M. Asakawa, H. Kono, H. Fujii, and Y. Matsumoto, “Decreased CD3 $\zeta$ molecules of T lymphocytes from patients with hepatocellular carcinoma associated with hepatitis C virus,” Hepatology Research, vol. 27, no. 4, pp. 272–278, 2003. View at Publisher · View at Google Scholar
21. G. Missale, E. Cariani, and C. Ferrari, “Role of viral and host factors in HCV persistence: which lesson for therapeutic and preventive strategies?” Digestive and Liver Disease, vol. 36, no. 11, pp. 703–711, 2004. View at Publisher · View at Google Scholar · View at PubMed
22. V. Francavilla, D. Accapezzato, M. De Salvo, et al., “Subversion of effector $\text{CD}{8}^{+}$ T cell differentiation in acute hepatitis C virus infection: exploring the immunological mechanisms,” European Journal of Immunology, vol. 34, no. 2, pp. 427–437, 2004. View at Publisher · View at Google Scholar · View at PubMed
23. S. Urbani, B. Amadei, D. Tola, et al., “PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion,” Journal of Virology, vol. 80, no. 22, pp. 11398–11403, 2006. View at Publisher · View at Google Scholar · View at PubMed
24. L. Golden-Mason, B. Palmer, J. Klarquist, J. A. Mengshol, N. Castelblanco, and H. R. Rosen, “Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific $\text{CD}{8}^{+}$ T cells associated with reversible immune dysfunction,” Journal of Virology, vol. 81, no. 17, pp. 9249–9258, 2007. View at Publisher · View at Google Scholar · View at PubMed
25. L. Golden-Mason, J. Klarquist, A. S. Wahed, and H. R. Rosen, “Cutting edge: programmed death-1 expression is increased on immunocytes in chronic hepatitis C virus and predicts failure of response to antiviral therapy: race-dependent differences,” Journal of Immunology, vol. 180, no. 6, pp. 3637–3641, 2008.
26. N. Nakamoto, H. Cho, A. Shaked, et al., “Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade,” PLoS Pathogens, vol. 5, no. 2, Article ID e1000313, 2009. View at Publisher · View at Google Scholar · View at PubMed
27. M. Kriegs, T. Bürckstümmer, K. Himmelsbach, et al., “The hepatitis C virus non-structural NS5A protein impairs both the innate and adaptive hepatic immune response in vivo,” Journal of Biological Chemistry, vol. 284, no. 41, pp. 28343–28351, 2009. View at Publisher · View at Google Scholar · View at PubMed
28. Z. Q. Yao, D. T. Nguyen, A. I. Hiotellis, and Y. S. Hahn, “Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway,” Journal of Immunology, vol. 167, no. 9, pp. 5264–5272, 2001.
29. D. J. Kittlesen, K. A. Chianese-Bullock, Z. Q. Yao, T. J. Braciale, and Y. S. Hahn, “Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation,” Journal of Clinical Investigation, vol. 106, no. 10, pp. 1239–1249, 2000.
30. Z. Q. Yao, A. Eisen-Vandervelde, S. Ray, and Y. S. Hahn, “HCV core/gC1qR interaction arrests T cell cycle progression through stabilization of the cell cycle inhibitor p27Kip1,” Virology, vol. 314, no. 1, pp. 271–282, 2003. View at Publisher · View at Google Scholar
31. K. V. Konan, T. H. Giddings Jr., M. Ikeda, K. Li, S. M. Lemon, and K. Kirkegaard, “Nonstructural protein precursor NS4A/B from hepatitis C virus alters function and ultrastructure of host secretory apparatus,” Journal of Virology, vol. 77, no. 14, pp. 7843–7855, 2003. View at Publisher · View at Google Scholar
32. P. Sarobe, J. J. Lasarte, A. Zabaleta, et al., “Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses,” Journal of Virology, vol. 77, no. 20, pp. 10862–10871, 2003. View at Publisher · View at Google Scholar
33. G. Szabo and A. Dolganiuc, “Subversion of plasmacytoid and myeloid dendritic cell functions in chronic HCV infection,” Immunobiology, vol. 210, no. 2–4, pp. 237–247, 2005. View at Publisher · View at Google Scholar
34. P.-Y. Lozach, H. Lortat-Jacob, A. de Lacroix de Lavalette, et al., “DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2,” Journal of Biological Chemistry, vol. 278, no. 22, pp. 20358–20366, 2003. View at Publisher · View at Google Scholar · View at PubMed
35. S. Pöhlmann, J. Zhang, F. Baribaud, et al., “Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR,” Journal of Virology, vol. 77, no. 7, pp. 4070–4080, 2003. View at Publisher · View at Google Scholar